The Trump administration’s shake-up of the United States’ public health apparatus in the wake of the COVID-19 pandemic has public health experts concerned about the country’s ability to respond to emerging disease outbreaks like hantavirus and Ebola.Whether that’s a concern for Congress, however, often depends on the member’s party — a reaction that should be familiar to anyone who lived through the highly partisan response to the pandemic.There are 41 Americans being monitored for hantavirus, a highly deadly pathogen, after an outbreak on a cruise ship off the coast of West Africa. And at least one American has tested positive for Ebola and six Americans had a high-risk exposure after an outbreak in the Democratic Republic of the Congo that is suspected of killing 223 people as of Monday, according to Centers for Disease Control and Prevention data.The overwhelming message is that Americans are at very low risk from these diseases. But some say lawmakers’ ad hoc funding of some public health programs, the expiration of others, and the Trump administration’s significant cuts at CDC aren’t helping.“There might be misconnections or missed opportunities for information sharing, which can add up to delays and response or understanding what’s happening on the ground,” said Josh Michaud, associate director for global public health policy at KFF. “Those kinds of things in an outbreak situation can be dangerous.” Democrats and public health organizations are raising concerns that the country’s public health apparatus is leaderless, underfunded and unprepared if hantavirus or Ebola spreads further.Republicans largely say it’s no sweat, noting that the risk to the American public is low.